Recursion to Present at 43rd Annual JP Morgan Healthcare Conference
Recursion (NASDAQ: RXRX), a clinical stage TechBio company, has announced that its co-founder and CEO Chris Gibson, PhD, will deliver a presentation at the 43rd Annual JP Morgan Healthcare Conference in San Francisco. The presentation is scheduled for Monday, January 13, at 7:30am PT (10:30am ET) in the Elizabethan Room A/B at the Westin St. Francis.
Dr. Gibson will provide updates on three key areas: Recursion's clinical pipeline, partnerships, and platform developments following the company's recent merger with Exscientia. The presentation will be accessible on Recursion's investor relations website for a minimum of 30 days after the event.
Recursion (NASDAQ: RXRX), un'azienda TechBio in fase clinica, ha annunciato che il suo co-fondatore e CEO Chris Gibson, PhD, terrà una presentazione alla 43ª Conferenza Annuale JP Morgan Healthcare a San Francisco. La presentazione è programmata per lunedì 13 gennaio, alle 7:30 PT (10:30 ET) nella Elizabethan Room A/B del Westin St. Francis.
Il Dr. Gibson fornirà aggiornamenti su tre aree chiave: il pipeline clinico di Recursion, le partnership e i progressi della piattaforma dopo la recente fusione dell'azienda con Exscientia. La presentazione sarà accessibile sul sito web delle relazioni con gli investitori di Recursion per almeno 30 giorni dopo l'evento.
Recursion (NASDAQ: RXRX), una empresa TechBio en etapa clínica, ha anunciado que su cofundador y CEO Chris Gibson, PhD, presentará en la 43ª Conferencia Anual de Salud de JP Morgan en San Francisco. La presentación está programada para el lunes 13 de enero, a las 7:30 am PT (10:30 am ET) en el Salón Elizabethan A/B del Westin St. Francis.
El Dr. Gibson proporcionará actualizaciones sobre tres áreas clave: el pipeline clínico de Recursion, las asociaciones y los desarrollos de la plataforma tras la reciente fusión de la compañía con Exscientia. La presentación estará accesible en la página web de relaciones con los inversores de Recursion durante un mínimo de 30 días después del evento.
Recursion (NASDAQ: RXRX)는 임상 단계의 TechBio 회사로, 공동 창립자이자 CEO인 Chris Gibson 박사가 샌프란시스코에서 열리는 제43회 JP Morgan 헬스케어 컨퍼런스에서 발표할 것이라고 발표했습니다. 발표는 1월 13일 월요일 오전 7:30 PT (오후 10:30 ET) Westin St. Francis의 Elizabethan Room A/B에서 예정되어 있습니다.
Gibson 박사는 Recursion의 임상 파이프라인, 파트너십 및 최근 Exscientia와의 합병 이후 플랫폼 개발에 대한 세 가지 주요 분야의 업데이트를 제공할 것입니다. 발표 내용은 Recursion의 투자자 관계 웹사이트에서 이벤트 후 최소 30일 동안 이용할 수 있습니다.
Recursion (NASDAQ: RXRX), une entreprise TechBio en phase clinique, a annoncé que son cofondateur et PDG Chris Gibson, PhD, présentera lors de la 43ème Conférence Annuelle JP Morgan Healthcare à San Francisco. La présentation est prévue pour le lundi 13 janvier à 7h30 PT (10h30 ET) dans la salle Elizabethan A/B du Westin St. Francis.
Le Dr Gibson fournira des mises à jour sur trois domaines clés : le pipeline clinique de Recursion, les partenariats et les développements de la plateforme suite à la récente fusion de l'entreprise avec Exscientia. La présentation sera accessible sur le site web des relations investisseurs de Recursion pendant un minimum de 30 jours après l'événement.
Recursion (NASDAQ: RXRX), ein Unternehmen der TechBio-Branche in der klinischen Phase, hat bekannt gegeben, dass sein Mitgründer und CEO Chris Gibson, PhD, eine Präsentation auf der 43. jährlichen JP Morgan Healthcare-Konferenz in San Francisco halten wird. Die Präsentation ist für Montag, den 13. Januar, um 7:30 Uhr PT (10:30 Uhr ET) im Elizabethan Room A/B im Westin St. Francis geplant.
Dr. Gibson wird Updates zu drei wichtigen Bereichen geben: der klinischen Pipeline von Recursion, Partnerschaften und Plattformentwicklungen nach der kürzlichen Fusion des Unternehmens mit Exscientia. Die Präsentation wird für mindestens 30 Tage nach der Veranstaltung auf der Website für Anlegerbeziehungen von Recursion verfügbar sein.
- None.
- None.
Salt Lake City, UT, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announces that co-founder and CEO Chris Gibson, PhD will present at the upcoming 43rd Annual JP Morgan Healthcare Conference in San Francisco.
On Monday, January 13, 7:30am PT (10:30am ET), at the Westin St. Francis in the Elizabethan Room A/B, Dr. Gibson will present updates on Recursion’s latest clinical pipeline, partnerships, and platform following the company’s recent combination with Exscientia. The talk will be available on Recursion’s website for at least 30 days following the presentation here: https://ir.recursion.com/news-events/events-presentations.
FAQ
When is Recursion (RXRX) presenting at the 2025 JP Morgan Healthcare Conference?
What topics will be covered in Recursion's (RXRX) JP Morgan Healthcare Conference presentation?
How long will Recursion's (RXRX) JP Morgan Healthcare Conference presentation be available online?
What is the significance of Recursion's (RXRX) recent combination with Exscientia?
